Efficacy and Safety of Metformin on Clinical and Metabolic Patterns in Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis

    December 2011
    Carmen Bouza, Marta Ruiz López, Raimundo Alcazar-Alcazar, Teresa López‐Cuadrado
    TLDR Metformin helps improve symptoms and reduce health risks in PCOS patients.
    The systematic review and meta-analysis evaluated the efficacy and safety of metformin in improving clinical, metabolic, and hormonal parameters in patients with Polycystic Ovary Syndrome (PCOS). The study aimed to assess metformin's role in reducing the risk of developing diabetes mellitus, metabolic syndrome, and cardiovascular disease. The findings suggested that metformin was effective in improving these parameters, indicating its potential benefit for patients with PCOS. However, as the document is from 2011, these conclusions might be outdated.
    Discuss this study in the Community →